Excellent post Ben!
Thank you.
Your statement addressing the final piece of the of Imugene's immunotherapy puzzle is a gem and worth highlighting again -
"although not fully understood by the market yet, Azer Cel adds the final piece Imugene’s immunotherapy puzzle. In doing so it enables them to take control of the huge untapped solid tumour market (expected to reach USD $901.27 billion by 2029), without relying on anyone else, including CAR T providers. Imugene now owns all the pie, not merely a piece of it!"
Imugene has the science, the expertise, the ambition, the finances and the data (soon to be released) to change the landscape in effective cancer treatment.
GLTAH - Go Team Imugene
Why IMU is a multi multi bagger, page-15940
-
- There are more pages in this discussion • 9,492 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.9¢ |
Change
0.005(9.26%) |
Mkt cap ! $433.6M | |||
| Open | High | Low | Value | Volume |
| 5.5¢ | 5.9¢ | 5.4¢ | $1.489M | 25.99M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 35252 | 5.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.0¢ | 1753430 | 24 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| IMU (ASX) Chart |